<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40967674</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2053-3624</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>17</Day></PubDate></JournalIssue><Title>Open heart</Title><ISOAbbreviation>Open Heart</ISOAbbreviation></Journal><ArticleTitle>Phenomapping-derived selection of fractional flow reserve or optical coherence tomography to personalise percutaneous coronary intervention.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e003453</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/openhrt-2025-003453</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">An evidence-based selection between fractional flow reserve (FFR) and optical coherence tomography (OCT) to drive percutaneous coronary intervention is still lacking.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients enrolled in the Fractional Flow Reserve vs. Optical Coherence Tomography to Guide Revascularization of Intermediate Coronary Stenoses (FORZA) trial and in the OCT-Features Of moRphology, coMposItion anD instABility of culprit and not culprit coronary pLaquE in ACS patient (OCT-FORMIDABLE) registry were included. Target vessel revascularisation (TVR) and major adverse cardiac events (MACE), a composite endpoint of cardiac death, myocardial infarction (MI) and TVR were considered as coprimary endpoints. Phenomapping with clustering was performed: incidence of outcomes according to FFR and OCT was explored.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">405 patients were treated according to OCT and 405 to FFR. Three different clusters were identified. 48% of the patients were included in the first cluster, presenting mainly with stable angina and a relevant burden of risk factors (cardiovascular risk factors, CVRFs). 21% of the patients were included in the second cluster, presenting with ST segment elevation MI (STEMI) and with low rates of CVRFs. 31% of the patients, being admitted mostly for non-STEMI (NSTEMI) and with high rates of CVRFs, were included in the third cluster. FFR and OCT performed similarly in terms of MACE and TVR in the first cluster. In the second cluster, rates of MACE were lower in the OCT arm (3% vs 12%, p 0.04), mainly driven by TVR (2% vs 6%, p 0.18). In the third cluster, rates of TVR were significantly reduced in the OCT arm (6% vs 14%, p 0.037) with a neutral impact on MACE (12% vs 15%, p 0.71).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Compared with a functional assessment, an OCT-based approach reduces revascularisation in patients with STEMI/NSTEMI, while FFR proved non-inferior for patients with stable angina.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>D'Ascenzo</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medical Sciences, University of Turin, Turin, Piedmont, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Caranzano</LastName><ForeName>Isabella</ForeName><Initials>I</Initials><Identifier Source="ORCID">0009-0004-8310-0652</Identifier><AffiliationInfo><Affiliation>AI and Computational Biomedicine Unit, Department of Medical Sciences, University of Turin, Turin, Piedmont, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Filippo</LastName><ForeName>Ovidio</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-4915-9501</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medical Sciences, University of Turin, Turin, Piedmont, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giacobbe</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medical Sciences, University of Turin, Turin, Piedmont, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leone</LastName><ForeName>Antonio Maria</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Cardiovascular Medicine, Catholic University of the Sacred Heart Faculty of Medicine and Surgery, Rome, Lazio, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanavia</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-3288-0631</Identifier><AffiliationInfo><Affiliation>AI and Computational Biomedicine Unit, Department of Medical Sciences, University of Turin, Turin, Piedmont, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravetti</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medical Sciences, University of Turin, Turin, Piedmont, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ugo</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Interventional Cardiology, Presidio Ospedaliero Sant'Andrea di Vercelli, Vercelli, Piedmont, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trani</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Cardiovascular Medicine, Catholic University of the Sacred Heart Faculty of Medicine and Surgery, Rome, Lazio, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amabile</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institut Mutualiste Montsouris, Paris, &#xce;le-de-France, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandrone</LastName><ForeName>Samuele</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medical Sciences, University of Turin, Turin, Piedmont, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aurigemma</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Catholic University of the Sacred Heart Faculty of Medicine and Surgery, Rome, Lazio, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Souteyrand</LastName><ForeName>Geraud</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University Hospital Centre Clermont-Ferrand, Clermont-Ferrand, Auvergne-Rh&#xf4;ne-Alpes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capodanno</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cardiovascular Departement, AOU Polyclinic 'G. Rodolico-San Marco', University of Catania, Catania, Sicily, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borzillo</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medical Sciences, University of Turin, Turin, Piedmont, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruno</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0019-0273</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medical Sciences, University of Turin, Turin, Piedmont, Italy cescobruno@hotmail.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boccuzzi</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Ospedale San Giovanni Bosco, Turin, Piedmont, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fariselli</LastName><ForeName>Piero</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-1811-4762</Identifier><AffiliationInfo><Affiliation>AI and Computational Biomedicine Unit, Department of Medical Sciences, University of Turin, Turin, Piedmont, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Ferrari</LastName><ForeName>Gaetano Maria</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medical Sciences, University of Turin, Turin, Piedmont, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iannaccone</LastName><ForeName>Mario</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0571-3918</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Ospedale San Giovanni Bosco, Turin, Piedmont, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burzotta</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-6569-9401</Identifier><AffiliationInfo><Affiliation>Catholic University of the Sacred Heart Faculty of Medicine and Surgery, Rome, Lazio, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017428">Clinical Trial, Phase III</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Open Heart</MedlineTA><NlmUniqueID>101631219</NlmUniqueID><ISSNLinking>2053-3624</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000066491" MajorTopicYN="N">Clinical Decision-Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017023" MajorTopicYN="N">Coronary Angiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="Y">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023921" MajorTopicYN="Y">Coronary Stenosis</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003331" MajorTopicYN="Y">Coronary Vessels</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053805" MajorTopicYN="Y">Fractional Flow Reserve, Myocardial</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062645" MajorTopicYN="Y">Percutaneous Coronary Intervention</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D041623" MajorTopicYN="Y">Tomography, Optical Coherence</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute Coronary Syndrome</Keyword><Keyword MajorTopicYN="N">Cardiac Catheterization</Keyword><Keyword MajorTopicYN="N">Percutaneous Coronary Intervention</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>19</Day><Hour>0</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>19</Day><Hour>0</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>18</Day><Hour>20</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40967674</ArticleId><ArticleId IdType="pmc">PMC12458727</ArticleId><ArticleId IdType="doi">10.1136/openhrt-2025-003453</ArticleId><ArticleId IdType="pii">openhrt-2025-003453</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Iannaccone M, Abdirashid M, Annone U, et al. Comparison between functional and intravascular imaging approaches guiding percutaneous coronary intervention: A network meta-analysis of randomized and propensity matching studies. Catheter Cardiovasc Interv. 2020;95:1259&#x2013;66. doi: 10.1002/ccd.28410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.28410</ArticleId><ArticleId IdType="pubmed">31400061</ArticleId></ArticleIdList></Reference><Reference><Citation>Tebaldi M, Biscaglia S, Fineschi M, et al. Fractional Flow Reserve Evaluation and Chronic Kidney Disease: Analysis From a Multicenter Italian Registry (the FREAK Study) Catheter Cardiovasc Interv. 2016;88:555&#x2013;62. doi: 10.1002/ccd.26364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.26364</ArticleId><ArticleId IdType="pubmed">26717890</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallone G, Bellettini M, Gatti M, et al. Coronary Plaque Characteristics Associated With Major Adverse Cardiovascular Events in Atherosclerotic Patients and Lesions: A Systematic Review and Meta-Analysis. JACC Cardiovasc Imaging. 2023;16:1584&#x2013;604. doi: 10.1016/j.jcmg.2023.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2023.08.006</ArticleId><ArticleId IdType="pubmed">37804276</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo B-K, Hu X, Kang J, et al. Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI. N Engl J Med. 2022;387:779&#x2013;89. doi: 10.1056/NEJMoa2201546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2201546</ArticleId><ArticleId IdType="pubmed">36053504</ArticleId></ArticleIdList></Reference><Reference><Citation>Burzotta F, Leone AM, Aurigemma C, et al. Fractional Flow Reserve or Optical Coherence Tomography to Guide Management of Angiographically Intermediate Coronary Stenosis. JACC: Cardiovascular Interventions. 2020;13:49&#x2013;58. doi: 10.1016/j.jcin.2019.09.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2019.09.034</ArticleId><ArticleId IdType="pubmed">31918942</ArticleId></ArticleIdList></Reference><Reference><Citation>Iannaccone M, Souteyrand G, Niccoli G, et al. Clinical impact of optical coherence tomography findings on culprit plaque in acute coronary syndrome: The OCT-FORMIDABLE study registry. Catheter Cardiovasc Interv. 2018;92:E486&#x2013;92. doi: 10.1002/ccd.27633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.27633</ArticleId><ArticleId IdType="pubmed">29745476</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ascenzo F, Iannaccone M, De Filippo O, et al. Optical coherence tomography compared with fractional flow reserve guided approach in acute coronary syndromes: A propensity matched analysis. Int J Cardiol. 2017;244:54&#x2013;8. doi: 10.1016/j.ijcard.2017.05.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2017.05.108</ArticleId><ArticleId IdType="pubmed">28629622</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamm CW, Bassand J-P, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J. 2011;32:2999&#x2013;3054. doi: 10.1093/eurheartj/ehr236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehr236</ArticleId><ArticleId IdType="pubmed">21873419</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann F-J, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. EuroIntervention. 2019;14:1435&#x2013;534. doi: 10.4244/EIJY19M01_01.</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/EIJY19M01_01</ArticleId><ArticleId IdType="pubmed">30667361</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen K, Alpert JS, Jaffe AS, et al. White, for the the Writing Group on Behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial InfarctionThird universal definition of myocardial infarction. Circulation. 2012;126:2020&#x2013;35. doi: 10.1161/CIR.0b013e31826e1058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0b013e31826e1058</ArticleId><ArticleId IdType="pubmed">22923432</ArticleId></ArticleIdList></Reference><Reference><Citation>Pijls NH, De Bruyne B, Peels K, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med. 1996;334:1703&#x2013;8. doi: 10.1056/NEJM199606273342604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199606273342604</ArticleId><ArticleId IdType="pubmed">8637515</ArticleId></ArticleIdList></Reference><Reference><Citation>Xaplanteris P, Fournier S, Pijls NHJ, et al. Five-Year Outcomes with PCI Guided by Fractional Flow Reserve. N Engl J Med. 2018;379:250&#x2013;9. doi: 10.1056/NEJMoa1803538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1803538</ArticleId><ArticleId IdType="pubmed">29785878</ArticleId></ArticleIdList></Reference><Reference><Citation>Prati F, Romagnoli E, Burzotta F, et al. Clinical impact of OCT findings during PCI: the CLI-OPCI Iistudy. J Am Coll Cardiol Img. 2015;8:1297&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">26563859</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali ZA, Maehara A, G&#xe9;n&#xe9;reux P, et al. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial. Lancet. 2016;388:2618&#x2013;28. doi: 10.1016/S0140-6736(16)31922-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)31922-5</ArticleId><ArticleId IdType="pubmed">27806900</ArticleId></ArticleIdList></Reference><Reference><Citation>De Filippo O, Cammann VL, Pancotti C, et al. Machine learning&#x2010;based prediction of in&#x2010;hospital death for patients with takotsubo syndrome: The intertak&#x2010;ml model. European J of Heart Fail. 2023;25:2299&#x2013;311. doi: 10.1002/ejhf.2983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2983</ArticleId><ArticleId IdType="pubmed">37522520</ArticleId></ArticleIdList></Reference><Reference><Citation>Segar MW, Patel KV, Ayers C, et al. Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis. Eur J Heart Fail. 2020;22:148&#x2013;58. doi: 10.1002/ejhf.1621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1621</ArticleId><ArticleId IdType="pubmed">31637815</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomou EK, Van Dijk D, Parise H, et al. A phenomapping-derived tool to personalize the selection of anatomical vs. functional testing in evaluating chest pain (ASSIST) Eur Heart J. 2021;42:2536&#x2013;48. doi: 10.1093/eurheartj/ehab223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab223</ArticleId><ArticleId IdType="pmc">PMC8488385</ArticleId><ArticleId IdType="pubmed">33881513</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato K, Yonetsu T, Kim SJ, et al. Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study. Circ Cardiovasc Imaging. 2012;5:433&#x2013;40. doi: 10.1161/CIRCIMAGING.112.973701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.112.973701</ArticleId><ArticleId IdType="pubmed">22679059</ArticleId></ArticleIdList></Reference><Reference><Citation>Erlinge D, Maehara A, Ben-Yehuda O, et al. Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study. Lancet. 2021;397:985&#x2013;95. doi: 10.1016/S0140-6736(21)00249-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00249-X</ArticleId><ArticleId IdType="pubmed">33714389</ArticleId></ArticleIdList></Reference><Reference><Citation>Puymirat E, Cayla G, Simon T, et al. Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction. N Engl J Med . 2021;385:297&#x2013;308. doi: 10.1056/NEJMoa2104650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2104650</ArticleId><ArticleId IdType="pubmed">33999545</ArticleId></ArticleIdList></Reference><Reference><Citation>Wald DS, Hadyanto S, Bestwick JP. Should fractional flow reserve follow angiographic visual inspection to guide preventive percutaneous coronary intervention in ST-elevation myocardial infarction? Eur Heart J Qual Care Clin Outcomes. 2020;6:186&#x2013;92. doi: 10.1093/ehjqcco/qcaa012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjqcco/qcaa012</ArticleId><ArticleId IdType="pubmed">32044975</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallone G, Angelini F, Fortuni F, et al. Angiography- vs. physiology-guided complete revascularization in patients with ST-elevation myocardial infarction and multivessel disease: who is the better gatekeeper in this setting? A meta-analysis of randomized controlled trials. Eur Heart J Qual Care Clin Outcomes. 2020;6:199&#x2013;200. doi: 10.1093/ehjqcco/qcaa007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjqcco/qcaa007</ArticleId><ArticleId IdType="pubmed">32011660</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne RA, Rossello X, Coughlan JJ, et al. ESC Guidelines for the management of acute coronary syndromes. ESC Scientific Document Group. 2023;44:3720&#x2013;826.</Citation><ArticleIdList><ArticleId IdType="pubmed">37622654</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JM, Choi KH, Song YB, et al. RENOVATE-COMPLEX-PCI Investigators. N Engl J Med. 2023;388:1668&#x2013;79. doi: 10.1056/NEJMoa2216607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2216607</ArticleId><ArticleId IdType="pubmed">36876735</ArticleId></ArticleIdList></Reference><Reference><Citation>Petch J, Di S, Nelson W. Opening the Black Box: The Promise and Limitations of Explainable Machine Learning in Cardiology. Can J Cardiol. 2022;38:204&#x2013;13. doi: 10.1016/j.cjca.2021.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2021.09.004</ArticleId><ArticleId IdType="pubmed">34534619</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xe4;ber L, Mintz GS, Koskinas KC, et al. Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. EuroIntervention. 2018;14:656&#x2013;77. doi: 10.4244/EIJY18M06_01.</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/EIJY18M06_01</ArticleId><ArticleId IdType="pubmed">29939149</ArticleId></ArticleIdList></Reference><Reference><Citation>Fournier S, Ciccarelli G, Toth GG, et al. Association of Improvement in Fractional Flow Reserve With Outcomes, Including Symptomatic Relief, After Percutaneous Coronary Intervention. JAMA Cardiol. 2019;4:370&#x2013;4. doi: 10.1001/jamacardio.2019.0175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2019.0175</ArticleId><ArticleId IdType="pmc">PMC6484787</ArticleId><ArticleId IdType="pubmed">30840026</ArticleId></ArticleIdList></Reference><Reference><Citation>van Bommel RJ, Masdjedi K, Diletti R, et al. Routine Fractional Flow Reserve Measurement After Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2019;12:e007428. doi: 10.1161/CIRCINTERVENTIONS.118.007428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.118.007428</ArticleId><ArticleId IdType="pubmed">31018666</ArticleId></ArticleIdList></Reference><Reference><Citation>Iannaccone M, Quadri G, Taha S, et al. Prevalence and predictors of culprit plaque rupture at OCT in patients with coronary artery disease: a meta-analysis. Eur Heart J Cardiovasc Imaging. 2016;17:1128&#x2013;37. doi: 10.1093/ehjci/jev283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jev283</ArticleId><ArticleId IdType="pubmed">26508517</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>